| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/03/2008 | US20080161418 Oils prepared by Kolbe electrolysis of fatty acids |
| 07/03/2008 | US20080161417 Xylitol Granules Capable of Directly Being Compressible Into Tablets and Preparation Process Thereof |
| 07/03/2008 | US20080161416 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents |
| 07/03/2008 | US20080161415 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents |
| 07/03/2008 | US20080161414 Compounds and methods for reducing undesired toxicity of chemotherapeutic agents |
| 07/03/2008 | US20080161413 Agent for increasing adiponectin in blood |
| 07/03/2008 | US20080161412 Industrial scale; heating in n-butanol then crystallizing |
| 07/03/2008 | US20080161411 Methods and compositions for treating pulmonary disorders using optically pure (r,r)-formoterol |
| 07/03/2008 | US20080161410 Aminoalkanol Derivatives |
| 07/03/2008 | US20080161409 Compositions for treatement of croup and methods of administering same |
| 07/03/2008 | US20080161408 Crystalline solid rasagiline base |
| 07/03/2008 | US20080161407 Methods for treating metabolic syndrome |
| 07/03/2008 | US20080161406 Novel formulations of alpha-2,4-disulfophenyl-N-tert-butylnitrone |
| 07/03/2008 | US20080161405 Multivessel package containing polyol such as mannose |
| 07/03/2008 | US20080161404 Metastatic prostate cancer |
| 07/03/2008 | US20080161402 Targeting the Reverse Mode of the Na+/Ca2+ Exchanger For the Treatment of Neurodegenerative Conditions |
| 07/03/2008 | US20080161401 Carbamic acid compounds comprising a sulfonamide linkage as hdac inhibitors |
| 07/03/2008 | US20080161400 Use of forms of propofol for treating diseases associated with oxidative stress |
| 07/03/2008 | US20080161399 Agent for reduction of oxidized albumin level |
| 07/03/2008 | US20080161398 Stimulation of in vivo production of proteins |
| 07/03/2008 | US20080161396 Affixing pesticide-containing band/tag to leg/wing of nesting fowl |
| 07/03/2008 | US20080161395 Derivatives of Aminobutanoic Acid Inhibiting Cpt |
| 07/03/2008 | US20080161394 Cosmetic composition comprising at least one volatile carbonic acid ester |
| 07/03/2008 | US20080161393 e.g. 1-{[( alpha -isobutanoyloxyethoxy)carbonyl]aminomethyl}-1-cyclohexane acetic acid; migraine, fibromyalgia, amyotrophic lateral sclerosis, irritable bowel syndrome, social phobia, Parkinson's disease, asthma, cough, or chronic obstructive pulmonary disease; sustained release |
| 07/03/2008 | US20080161392 Based on 3-iodo-2-propynyl butylcarbamate (IPBC), a liquid carrier and a stabilizer; free of benzoic acid, propionic acid, salicylic acid, sorbic acid, 4-hydroxybenzoic acid, dehydroacetic acid and 10-undecylenic acid |
| 07/03/2008 | US20080161391 Novel curcumin analogues and uses thereof |
| 07/03/2008 | US20080161389 Method of treating ocular hypertension and intestinal disorders by using dianhydrohexite mononitrate derivatives |
| 07/03/2008 | US20080161388 Dissolving free base in diethylether and removing |
| 07/03/2008 | US20080161387 For use in dietary supplements, animal feeds, and cosmetics; bioavailability |
| 07/03/2008 | US20080161386 increasing blood flow in brain vasculature with polyphenols such as flavanols, procyanidins; mixture of catechin, epicatechin, and (hydrophenyl-hydrochromene) derivatives; brain activation confirms by NMR images |
| 07/03/2008 | US20080161385 Isoflavone containing plant extracts; health foods promoting estradiol secretion; osteoporosis prevention, improving fat metabolism |
| 07/03/2008 | US20080161384 Topical skin application; immediate relief |
| 07/03/2008 | US20080161382 Suspensions of docetaxel particles with protein or polymer stabilizing agent; shorter administration times; reducing toxicity and hypersensitivity side effects |
| 07/03/2008 | US20080161381 Compositions Comprising An No Donor And A Dithiolane And Their Use For Improvement Of Sexual Function |
| 07/03/2008 | US20080161380 Amino acid composition |
| 07/03/2008 | US20080161379 Methods of Treating Diabetes Mellitus |
| 07/03/2008 | US20080161378 e.g. 3-methyl-1-phenyl-2-pyrazolin-5-one; generic name: "Edaravone" commercial name: "Radicut" (used as a cerebroprotective agent), when its dose regimens, dosages and administration periods are changed |
| 07/03/2008 | US20080161377 Use of L-2-thiohistidine or one of its derivatives as a depigmenting agent in cosmetics |
| 07/03/2008 | US20080161376 Using antimycotic formulation containing propylene glycol, disodium edta, mineral oil, polyglyceryl-3-oleate, glyceryl monoisostearate, microcrystalline wax, silicon dioxide, methylparaben, propylparaben, butoconazole nitrate in water and sorbitol solution |
| 07/03/2008 | US20080161375 Solubilizing of metronidazole |
| 07/03/2008 | US20080161374 Pyrazole compounds and uses related thereto |
| 07/03/2008 | US20080161373 Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor xia inhibitors |
| 07/03/2008 | US20080161372 Methods for the Treatment of Hypertension |
| 07/03/2008 | US20080161371 Modulators of cystic fibrosis transmembrane conductance regulator |
| 07/03/2008 | US20080161370 Benzothiazol-2-one derivatives as lipase and phospholipase inhibitors |
| 07/03/2008 | US20080161369 Open label, single arm, two stage, multicenter study; patients who have not responded to taxane/platinum therapy or have relapsed within six months |
| 07/03/2008 | US20080161368 Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome |
| 07/03/2008 | US20080161366 Aminoalkyl substituted aryl sulfamide derivatives and methods of their use |
| 07/03/2008 | US20080161365 Methylene Derivatives |
| 07/03/2008 | US20080161364 Enteric Medicinal Composition For Oral Use |
| 07/03/2008 | US20080161363 2-Aminopyridine Compounds Useful as Beta-Secretase Inhibitors For the Treatment of Alzheimer's Disease |
| 07/03/2008 | US20080161362 e.g. 2-Carboxy-3-benzyloxy-6-methyl-pyran-4(1H)-one; matrix metalloproteinase inhibitors, histone deacetylase inhibitors, or anthrax lethal factor inhibitors; cell growth and division, bone growth, wound healing, embryogenesis, angiogenesis; cardiovascular disease, stroke, arthritis, tumor metastasis |
| 07/03/2008 | US20080161361 e.g. 5-methyl-1-(4-hydroxylphenyl)-2-(1H)-pyridone; pirfenidone derivatives; enhancing therapeutic efficacy of cytotoxic agent, immunosuppressant, and radiation therapy; fibrosis of the kidney or lung, radiation pneumonitis, interstitial pneumonia; cancer: lung, bone marrow, breast, colon, pancreas |
| 07/03/2008 | US20080161360 Methods of using and compositions comprising immunomodulatory compounds for the treatment and management of myelodysplastic syndromes |
| 07/03/2008 | US20080161359 Crystalline form of rabeprazole sodium |
| 07/03/2008 | US20080161358 Cyanoamide Compounds Useful as Malonyl-COA Decarboxylase Inhibitors |
| 07/03/2008 | US20080161357 Devices and methods for pain management |
| 07/03/2008 | US20080161356 Precise, long duration; metered systemic delivery of sufentanil; minimizing tissue trauma; reducing gastrointestinal and respiratory system side effects |
| 07/03/2008 | US20080161355 Combinations of Pyrazole Kinase Inhibitors and Further Antitumor Agents |
| 07/03/2008 | US20080161354 Stable s-nitrosothiols, method of synthesis and use |
| 07/03/2008 | US20080161353 8-Hydroxy quinoline derivatives |
| 07/03/2008 | US20080161352 Pain, eating disorders, neurodegenerative disorders, memory impairment; attention deficit syndrome, opioid tolerance, drug addiction; (4-oxothiochroman-3,3-diyl)bis(methylene)bis(3-(trifluoromethyl)benzoate for example |
| 07/03/2008 | US20080161351 Peroxisome proliferator-activated receptor (PPAR) delta modulators; inhibitors of inducible nitric oxide synthase (iNOS) or tumor necrosis factor (TNF); metabolic disorders, inflammatory diseases and cancer |
| 07/03/2008 | US20080161350 Use of quinoline derivatives with anti-integrase effect and applications thereof |
| 07/03/2008 | US20080161349 Tocopherols, tocotrienols, other chroman and side chain derivatives and uses thereof |
| 07/03/2008 | US20080161348 Use of pitavastatin or salt thereof to treat rheumatoid arthritis |
| 07/03/2008 | US20080161347 Substituted Aryl and Heteroaryl Derivatives, Compositions Containing Such Compounds and Methods of Use |
| 07/03/2008 | US20080161346 Pyridines or pyrimidines having 4-(hydrogenated 1-pyridyl- or hydrogenated 1-isoquinolyl rings, e.g., N-(4-chlorophenyl)-2-(pyridin-4-ylmethyl)-1,2,3,4-tetrahydroisoquinoline-5-carboxamide; kinase inhibitors; inflammation, angiogenesis and cancer |
| 07/03/2008 | US20080161345 Aryl Sulfonamides |
| 07/03/2008 | US20080161344 Melanin Concentrating Hormone Receptor Ligands: Substituted Tetrahydroisoquinoline Analogues |
| 07/03/2008 | US20080161343 Sigma 2 Receptor Ligands and Therapeutic Uses Therefor |
| 07/03/2008 | US20080161342 Specifically mutilin 14-(exo-8-methyl-8-azabicyclo[3.2.1]oct-3-ylsulfanyl)-acetate (SB 268091); use as antibiotic; crystallization from isopropanol; improved bioavailability, and/or physical properties, for example solubility or flow properties |
| 07/03/2008 | US20080161341 Novel imidazothiazoles and imidazoxazoles |
| 07/03/2008 | US20080161340 Tetrahydroquinilinones, tetrahydronaphthyridones and derivatives thereof |
| 07/03/2008 | US20080161339 Novel Thio-Containing Hydroxy-6-Phenylphenanthridines and their Use as Pde4 Inhibitors |
| 07/03/2008 | US20080161338 Novel Pyrrolodihydroisoquinolines as Pde 10 Inhibitors |
| 07/03/2008 | US20080161337 Use of Rifaximin for the Treatment of Chronic Prostatitis |
| 07/03/2008 | US20080161336 Orally bioavailable CCI-779 formulations |
| 07/03/2008 | US20080161335 Oral formulations |
| 07/03/2008 | US20080161334 Macrolides |
| 07/03/2008 | US20080161333 e.g.1'-[(6-chloro-1H-indol-3-yl)carbonyl]-7H-spiro[pentane[3,4-b]pyridine-5,4'-piperidine]; vasopressin V1a receptor antagonist; antidepressant and anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome |
| 07/03/2008 | US20080161332 e.g.1'-[(6-chloro-1H-indol-3-yl)carbonyl]-7H-spiro[furo[3,4-b]pyridine-5,4'-piperidine]; vasopressin V1a receptor antagonist; antidepressant and anxiolytic agent; dysmenorrhea, hypertension, chronic heart failure, inappropriate secretion of vasopressin, liver cirrhosis, nephrotic syndrome |
| 07/03/2008 | US20080161331 e.g. 1-{3-[4-(4,4-dimethyl-4,5-dihydro-1,3-oxazol-2-yl)phenoxy]propyl}piperidine; histamine H3 receptor antagonist; anxiolytic agent, antidepressant, cognition activator; neurodegenerative diseases, eating disorder, attention deficit disorder, Alzheimer's, Parkinson's diseases, schizophrenia |
| 07/03/2008 | US20080161330 e.g. 5-chloro-2-{4-methoxy-2-[3-(pyrid-2-yl)isoxazol-5-yl]pyrrolidin-1-yl}-4-(5-methyl-1H-pyrazol-3-ylamino)pyrimidine; insulin-like growth factor (somatomedin) antagonist; antiproliferation, anticarcinogenic, antitumor agent |
| 07/03/2008 | US20080161329 Pharmaceutical uses |
| 07/03/2008 | US20080161328 5-Substituted quinazolinone derivatives and compositions comprising and methods of using the same |
| 07/03/2008 | US20080161327 Substituted 9-Alkyladenines and the Use Thereof |
| 07/03/2008 | US20080161326 Novel Sulfone Amide Amide Derivatives |
| 07/03/2008 | US20080161325 e.g. N1-[3-amino-4-(3,5-difluorophenyl)-2-hydroxybutyl]-3-(butylsulfonyl)-N1-(3-ethylbenzyl)-D-alaninamide dihydrochloride; inhibitors of amyloid beta-secretase enzyme; neurodegenerative diseases: Alzheimer's, Parkinson's diseases, Down's syndrome |
| 07/03/2008 | US20080161324 Screening for effective drug combinations; single stranded RNA, flaviviridae and/or hepatic viruses; reducing side effects |
| 07/03/2008 | US20080161323 Piperazine Derivatives of Alkyl Oxindoles |
| 07/03/2008 | US20080161322 e.g. 1-[2-tert-Butyl-6-(trifluoromethyl)pyrimidin-4-yl]-4-[3-(2-oxo-3,4-dihydroquinolin-1(2H)-yl)propyl]piperazin-4-ium chloride3,4-Dihydroquinolin-2(1H)-one; dopamine D3 receptor antagonists or agonists; antidepressant, schizophrenia, Parkinson's disease |
| 07/03/2008 | US20080161321 Use of Renin Inhibitors in Therapy |
| 07/03/2008 | US20080161320 Fused bicyclic pyrimidines as ptk inhibitors containing a zinc binding moiety |
| 07/03/2008 | US20080161319 Methods For Treating Inflammatory Conditions |
| 07/03/2008 | US20080161318 Novel compositions and uses thereof |
| 07/03/2008 | US20080161317 Inhibitors of Akt activity |
| 07/03/2008 | US20080161316 Indoles |
| 07/03/2008 | US20080161315 Indoles |
| 07/03/2008 | US20080161314 Novel Diazabicyclic Aryl Derivatives and Their Medical Use |